June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Angiogenin is a Requirement for Active Stromal tissue Formation and Recurrence of Pterygium
Author Affiliations & Notes
  • Jae Chan Kim
    Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Republic of Korea
  • Kyoung Woo Kim
    Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Republic of Korea
  • Soo Hyun Park
    Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Republic of Korea
  • Yeoun Sook Chun
    Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Republic of Korea
  • Sung Wook Wee
    Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Jae Chan Kim, None; Kyoung Woo Kim, None; Soo Hyun Park, None; Yeoun Sook Chun, None; Sung Wook Wee, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5448. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jae Chan Kim, Kyoung Woo Kim, Soo Hyun Park, Yeoun Sook Chun, Sung Wook Wee; Angiogenin is a Requirement for Active Stromal tissue Formation and Recurrence of Pterygium. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5448.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Angiogenin is originally identified as a tumor angiogenic factor, and its biological activity is extended to stimulating cell migration and proliferation, and more recently to promoting cell survival. Because angiogenesis and cell proliferation are well known prerequisites for tissue formation of pterygium, we investigated the expression profiles of angiogenin as a novel factor related with pathogenesis of pterygium.

Methods: In cultured stromal fibroblasts and surface epithelial cells of pterygia (42 eyes) and normal conjunctiva (12 eyes) as a control group, angiogenin expression was analyzed by RT-PCR at mRNA level and by Western blotting at protein level. Immunohistochemistry was used to assess the localization of angiogenin-expressing cells in pterygia. The pattern of expression in cultured cells and excised tissues was comparatively evaluated according to representative clinical indices based on recurrency, grade based on pterygial body morphology (T1-T3) or vascularity (V1-V3), and disease activity.

Results: Angiogenin expression was higher in the stromal fibroblasts than epithelial cells. In cultured fibroblasts of pterygia, the recurred, T3 grade or active (recurred or occurred within recent 6 months) pterygia revealed significantly higher expression than the others at both mRNA and protein levels. In immunohistochemistry, angiogenin was strongly expressed in stromal layer of active and recurred pterygia with T3 grade, especially at the perivascular area in contrast to scarce expression in normal conjunctiva. Pterygia with high vascularity had a tendency of relatively higher expression of angiogenin.

Conclusions: Angiogenin expressed in pterygia might contribute to active stromal tissue formation with angiogenesis and further recurrence. This newly uncovered finding suggests the possible effect of angiogenin to stimulate the stromal fibroblasts to proliferate in pathogenesis of pterygium.

Keywords: 665 pterygium • 654 proliferation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×